National and Kapodistrian University of Athens
Illuminating the role of cancer associated fibroblasts (CAFs) in tumor development and response to therapy
Abstract
dc:descriptionCancer represents the second leading cause of death globally according to the World Health Organization (WHO). The immunosuppressive and hypoxic networks of the tumor microenvironment (TME) impede the elicitation of potent anti-tumor immune responses and impair the success of immunotherapy. Among the constituents of the TME, cancer-associated fibroblasts (CAFs) represent a dominant and highly heterogeneous cell population, serving multi-faceted roles in all stages of cancer progression. Importantly, their immunomodulatory functions within the TME are still poorly understood. The present thesis explores the contribution of CAFs in tumor development, immune evasion and immunotherapy resistance, using state-of-the-art mouse models and biopsies from cancer patients. Herein, we demonstrated that α-SMA+ CAFs accumulate in the TME and express immune checkpoint ligands PD-L1 and PD-L2, facilitating the creation of an immunosuppressive tumor stroma. Notably, α-SMA+ CAFs exhibit a tolerogenic phenotype and affect immune cell infiltration and the proteomic contexture of the TME. Moreover, these cells can phagocytose, process and present tumor antigens, instructing movement arrest, activation and proliferation of T regulatory (Treg) cells in an MHC II-dependent manner. Importantly, our data reveal the formation of immune synapses between CAFs and Treg cells, which are reinforced by CAF autophagy and persist despite PD-L1 blockade, indicating that these interactions may constitute a resistance mechanism against immune checkpoint inhibitors. Knocking down autophagy in CAFs led to their inflammatory reprogramming, which attenuated tumor development while reducing Treg cell infiltration into the TME and CAF-mediated Treg activation. Finally, combination of autophagy depletion along with administration of dual immune checkpoint blockade therapy resulted in inhibition of tumor growth and a greater presence of effector T cells in the TME, hinting that targeting of this catabolic pathway in CAFs may ameliorate resistance to immunotherapy. Overall, in this study we analyze the immunosuppressive function of α-SMA+ CAFs in the TME, revealing the formation of synapses between α-SMA+ CAFs and Tregs in an autophagy-dependent manner. Our findings underscore the therapeutic potential of disrupting these cell-to-cell interactions between the two cell types or inhibiting CAF autophagy. Ultimately, the results presented here provide a better understanding of the mechanisms and molecules CAFs utilize, which stimulate tumor development and resistance to therapy, while offering new avenues for development of anti-cancer therapies, through combination of CAF-targeted therapies with immune checkpoint inhibition.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Varveri, Athina
- Βαρβέρη, Αθηνά
Subjects
dc:subject × 20- Καρκίνος
- Ανοσολογία
- Τ ρυθμιστικά λεμφοκύτταρα
- Αυτοφαγία
- Ανοσολογική σύναψη
- Ινοβλάστες
- Cancer
- Immunology
- T regulatory lymphocytes
- Autophagy
- Immune synapse
- Fibroblasts
- Βιολογία
- Φυσικές Επιστήμες
- Βιολογία κυττάρου
- Βιοχημεία και Μοριακή βιολογία
- Biological Sciences
- Natural Sciences
- Cell Biology
- Biochemistry and Molecular Biology
Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/58681